tirzepatide for cardiovascular disease demonstrates protection in head-to-head trial with dulaglutide Original Article: Cardiovascular Outcomes with
Description
This adaptive thermogenesis can slow weight loss over time and, if caloric intake isn't adjusted accordingly, may contribute to weight stabilization or modest regain
During this time, prepare your syringe, verify the dose, and perform a final visual check of the solution for particles or discoloration
Dispose of the used syringe immediately in your sharps container
[1] Protect from light, do not freeze, and discard if frozen
doi: 10.1126/scitranslmed.3007218
Tirzepatide (Compounded): A dual GLP-1/GIP receptor agonist that regulates appetite, improves metabolic function, and enhances fat loss
